.

Alzheimer’s cure behind the boom in brain science (Financial Review):

“Biogen is one of many members of big pharma seeking the blockbuster drug which will inevitably be worth multiple billions of dollars. Big pharma in the US spends about $US5 billion a year on Alzheimer’s research and development.

Exponential growth in the disease over the past decade has not been accompanied by the development of approved drugs. In fact, Read the rest of this entry »

San Francisco-based online ‘brain registry’ seeks volunteers to transform research (San Jose Mercury News):

“By volunteering — repeatedly over time — participants join a pool of research subjects in the new Brain Health Registry, opened Tuesday, for studies on brain diseases such as Alzheimer’s and Parkinson’s, as well as depression, post-traumatic stress disorder and other neurological ailments. Read the rest of this entry »

A Quiet “Sea Change” in Medicare (The New York Times):

“In January, Medicare officials updated the agency’s policy manual –the rule book for everything Medicare does– to erase any notion that improvement Read the rest of this entry »

Israeli medical device offers new Alzheimer’s treatment (Reuters):

“According to Alvaro Pascual-Leone, director of the hospital’s Berenson-Allen Centre for Non-invasive Brain Stimulation, brain stimulation – or transcranial magnetic stimulation – involves a very low current applied to a specific part of the brain and Read the rest of this entry »

NFL donates $30 million to National Institutes of Health (press release):

“The National Football League will provide $30 million in funding for medical research to the Foundation for the National Institutes of Health (FNIH), NFL Commissioner Roger Goodell announced today Read the rest of this entry »